Table II.
Antibiotics susceptibility patterns of ESBL-producer and non-ESBL producer Gram negative isolates (n=18).
| Antibiotics | Susceptibility patterns | ||||
|---|---|---|---|---|---|
| Sensitive | Intermediate | Resistant | |||
| ESBL-producer | Non-ESBL producer | Total | |||
| IPM | 18 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| CIP | 13 (72.2%) | 1 (5.6%) | 2 (11.1%) | 2 (11.1%) | 4 (22.2%) |
| STX | 6 (33.3%) | 0 (0%) | 5 (27.8%) | 7 (38.9%) | 12 (66.7%) |
| AMC | 2 (11.1%) | 1 (5.6%) | 8 (44.4%) | 7 (38.9%) | 15 (83.3%) |
ESBL: Extended Spectrum β- Lactamase producer, IPM: Imipenem, CIP: Ciprofloxacin, STX: Co-trimoxazole, AMC: Amoxicillin. Values are numbers and percentages of Gram negative isolates according to their susceptibility patterns to different antibiotics.